Form 4 for NXDT NEXPOINT DIVERSIFIED REAL ESTATE TRUST
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001437749-23-015469 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-05-22 | 2023-05-18+ | NXDT | DONDERO JAMES D | See Remarks, Dir, 10% | P - Purchase | $10.22 | +30.4K | 15.2K | New | +$311.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | P | A | 5,024 | $9.70 | 255,076.39 | I See Footnote | — | — | (F4) 28,011 shares are held by Drugcrafters, 65,714.39 shares are held by PCMG Trading Partners XXIII, L.P. and 175,780 shares are held by Governance Re Ltd. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2023-05-18 | P | A | 8,558 | $9.65 | 250,052.39 | I See Footnote | — | — | (F4) 28,011 shares are held by Drugcrafters, 65,714.39 shares are held by PCMG Trading Partners XXIII, L.P. and 175,780 shares are held by Governance Re Ltd. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 3 | Common | 5.50% Series A Cumulative Preferred Shares | 2023-05-19 | P | A | 205 | $15.25 | 15,411 | I See Footnote | — | — | (F1) These shares are held by Drugcrafters, L.P. ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 4 | Common | Common Stock | 2023-05-19 | P | A | 14,429 | $9.91 | 269,505.39 | I See Footnote | — | — | (F4) 28,011 shares are held by Drugcrafters, 65,714.39 shares are held by PCMG Trading Partners XXIII, L.P. and 175,780 shares are held by Governance Re Ltd. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
| 5 | Common | 5.50% Series A Cumulative Preferred Shares | 2023-05-18 | P | A | 2,202 | $15.24 | 15,206 | I See Footnote | — | — | (F1) These shares are held by Drugcrafters, L.P. ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |